AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 41 filers reported holding AGILE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -57.7% | 144,816 | 0.0% | 0.00% | – |
| Q4 2021 | $71,000 | -70.0% | 144,816 | -41.3% | 0.00% | – |
| Q3 2021 | $237,000 | +0.9% | 246,720 | +40.0% | 0.00% | – |
| Q2 2021 | $235,000 | -84.8% | 176,270 | -76.3% | 0.00% | – |
| Q1 2021 | $1,547,000 | -31.2% | 743,601 | -5.0% | 0.00% | – |
| Q4 2020 | $2,247,000 | -8.7% | 782,733 | -3.3% | 0.00% | -100.0% |
| Q3 2020 | $2,461,000 | +3.4% | 809,272 | -5.4% | 0.00% | 0.0% |
| Q2 2020 | $2,379,000 | +840.3% | 855,879 | +529.1% | 0.00% | – |
| Q1 2020 | $253,000 | -6.3% | 136,056 | +25.9% | 0.00% | – |
| Q4 2019 | $270,000 | +225.3% | 108,048 | +54.7% | 0.00% | – |
| Q3 2019 | $83,000 | +38.3% | 69,826 | +70.6% | 0.00% | – |
| Q2 2019 | $60,000 | -3.2% | 40,923 | 0.0% | 0.00% | – |
| Q1 2019 | $62,000 | +158.3% | 40,923 | 0.0% | 0.00% | – |
| Q4 2018 | $24,000 | +60.0% | 40,923 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | -25.0% | 40,923 | -0.2% | 0.00% | – |
| Q2 2018 | $20,000 | -81.0% | 41,008 | 0.0% | 0.00% | – |
| Q1 2018 | $105,000 | +2.9% | 41,008 | +7.7% | 0.00% | – |
| Q4 2017 | $102,000 | -18.4% | 38,075 | +35.5% | 0.00% | – |
| Q3 2017 | $125,000 | +19.0% | 28,097 | -0.0% | 0.00% | – |
| Q2 2017 | $105,000 | -78.0% | 28,108 | -81.1% | 0.00% | – |
| Q1 2017 | $477,000 | -41.0% | 148,876 | +4.9% | 0.00% | – |
| Q4 2016 | $809,000 | -18.0% | 141,928 | +0.5% | 0.00% | – |
| Q3 2016 | $986,000 | -8.9% | 141,199 | -0.7% | 0.00% | – |
| Q2 2016 | $1,082,000 | +31.3% | 142,148 | +7.2% | 0.00% | – |
| Q1 2016 | $824,000 | -18.0% | 132,622 | +28.7% | 0.00% | – |
| Q4 2015 | $1,005,000 | +45.2% | 103,027 | +0.3% | 0.00% | – |
| Q3 2015 | $692,000 | +286.6% | 102,752 | +392.6% | 0.00% | – |
| Q2 2015 | $179,000 | +31.6% | 20,861 | +41.7% | 0.00% | – |
| Q1 2015 | $136,000 | +112.5% | 14,718 | +41.8% | 0.00% | – |
| Q4 2014 | $64,000 | -15.8% | 10,378 | 0.0% | 0.00% | – |
| Q3 2014 | $76,000 | – | 10,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |